Online prediction platforms like Kalshi and Polymarket are expanding their offerings to include financial speculation on pharmaceutical drug trial outcomes and regulatory approvals. This burgeoning trend allows individuals to bet on scientific and medical milestones, prompting significant debate within the healthcare and financial sectors regarding potential ethical conflicts and the integrity of medical research and development.
